| DC Field | Value | Language |
|---|
| dc.contributor.author | Koledova, Yu. V. | - |
| dc.contributor.author | Bychkovskii, N. I. | - |
| dc.contributor.author | Mitkevich, V. A. | - |
| dc.contributor.author | Makarov, A. A. | - |
| dc.contributor.author | Poluektov, Yu. M. | - |
| dc.date.accessioned | 2026-03-18T13:11:33Z | - |
| dc.date.available | 2026-03-18T13:11:33Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Efficacy and safety profiles of monoclonal antibodies used in the therapy of Alzheimer’s disease / Yu.V. Koledova, N.I. Bychkovskii, V.A. Mitkevich [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №4.-P. 1-16. - Doi: 10.18413/rrpharmacology.11.842. - Refer.: p. 13-16. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/66354 | - |
| dc.description.abstract | Aim: to summarize efficacy, side effects and mortality rates of monoclonal antibodies based on the results of clinical trials in comparison with conventional therapy | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | Alzheimer’s disease | ru |
| dc.subject | therapy | ru |
| dc.subject | efficacy | ru |
| dc.subject | safety | ru |
| dc.subject | monoclonal antibodies | ru |
| dc.title | Efficacy and safety profiles of monoclonal antibodies used in the therapy of Alzheimer’s disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 4
|
